Twist Bioscience: Fiscal Q1 Earnings Snapshot

In this article:

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Friday reported a loss of $43 million in its fiscal first quarter.

The South San Francisco, California-based company said it had a loss of 75 cents per share.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 80 cents per share.

The maker of synthetic DNA for the biotechnology industry posted revenue of $71.5 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $67.4 million.

Twist Bioscience expects full-year revenue in the range of $288 million to $293 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TWST at https://www.zacks.com/ap/TWST

Advertisement